Table 1: Shows the clinical characteristics of 6 neonates with Pseudomonas aeruginosa sepsis.
Case | Birth weight (Grams) | Sex | Gestational Age (Weeks) | Day of diagnosis (Days) | Clinical Features | Empirical Antibiotic | Rationalized Antibiotic | Inpatient Stay (Days) | Outcome | Morbidity |
1 | 1009 | M | 30 | 24 | Bradycardia, desaturations and feed intolerance | Vanc, Imi | Vanc, Gent | 73 | Survived | No complications |
2 | 696 | F | 24 | 7 | Septic shock | Vanc, Imi | Mero, Gent | 165 | Survived | BPD, IVH |
3 | 653 | M | 25 | 4 | Hyperglycemia, Increasing ventilator requirement, Septic Shock | BP, Cefta | Imi, Gent | 11 | Died | - |
4* | 840 | M | 25 | 12 | Septic Shock | Vanc, Imi | IVIG added | 12 | Died | - |
5* | 597 | M | 23 | 5 | Septic Shock, DIC, Renal Failure | BP, Gent, Fluclox | Vanc, Imi, Fluclox | 7 | Died | - |
6 | 1096 | F | 26 | 6 | Septic Shock, DIC, Renal Failure | Vanc, Imi | Mero, Cipro | 112 | Survived | BPD, IVH |
*Prior colonization with Pseudomonas aeruginosa.
Vanc: Vancomycin, Imi: Imipenem, Gent: Gentamicin, Mero: Meropenem, BP: Benzylpenicillin, Flucox: Flucloxacillin, Cipro: Ciprofloxacin, BPD: Bronchopulmonary dysplasia, IVH: Intraventricular Hemorrhage